Common Patent Issues

Patent pic

Robert Kasirer was inspired to enter the healthcare sector because of his parents’ sterling reputation in the nursing home industry. An attorney and innovator, Robert Kasirer has applied for a patent on a new system of applications addressing the needs of intermediate care facilities, such as nursing homes and hospitals.

Filing for a patent is a complicated process. If you’re applying for a patent, be prepared for the following issues.

1. You will be asked to pay a filing fee, which will not be refunded even if the patent fails. If your application is accepted, you will need to pay an issue fee.

2. You will be asked for maintenance fees three and one-half years, seven and one-half years, and 11 and one-half years from the date the patent is granted.

3. The biggest mistake that filers make is failing to fully describe their inventions. You should include descriptions of every feature of the invention in enough detail that someone familiar with the industry can replicate the design.


Research at the Penn Institute on Aging


Penn Institute on Aging pic
Penn Institute on Aging

Robert Kasirer has held several leadership positions in the nursing home industry, including an executive role at Golden State Health Centers, Inc. Leveraging his experience, Robert Kasirer serves as a member of the External Advisory Board at the University of Pennsylvania’s (Penn) Institute on Aging.

Founded in 1979, the Penn Institute on Aging seeks to enhance the well-being of seniors through clinical research and educational programs on the University of Pennsylvania campus. Led by Dr. John Q. Trojanowski, some 300 fellows from 12 Penn schools and outside institutions conduct research on age-related issues such as neurodegenerative diseases, longevity, law, public policy, economics, and nursing.

In 2012, the Penn Institute on Aging received the second highest amount of research funding from the National Institute of Health’s National Institute on Aging. Current research by the Penn Institute on Aging includes studies on Alzheimer’s disease, Parkinson’s disease, age-related inflammation, and cancer.

About Institute on Aging’s Social Day Program


Social Day Program pic
Social Day Program

After completing his undergraduate studies at New York University and then obtaining a juris doctor from St. John’s University School of Law, Robert Kasirer went on to invent a computer-system user interface for managing healthcare facilities. Since 2005, Robert Kasirer has also served as a member on the Institute on Aging’s external advisory board.

Headquartered in San Francisco, the Institute on Aging is a non-profit organization whose mission it is to provide the best possible healthcare for aging adults. Providing all-inclusive health services, education opportunities, and social programs, the Institute on Aging prides itself on its innovative methods to serve people from all backgrounds.

The Institute on Aging’s Social Day Program can help isolated individuals become active and engaged in their community. IOA’s staff aids seniors in group exercise, transportation, and intellectual stimulation, plus provides homemade meals containing healthy, fresh ingredients. Although being in one’s own home can be comforting, the IOA’s center provides a person with a chance to connect with others and maintain a sense of self.

Encouraging Progress against Alzheimer’s from UCLA Longevity Center

Robert Kasirer is a real estate professional with an extensive background in senior healthcare and housing for individuals with disabilities. A long-time supporter of medical research at the UCLA Longevity Center (formerly the UCLA Center on Aging), Robert Kasirer has lent his financial support to research some of the most serious medical conditions affecting older Americans.

Even though it is the sixth-leading cause of death in Americans, Alzheimer’s has largely remained an enigma since its first reports over a century ago. However, recent studies from UCLA and Buck Institute researchers may point to major treatment pathways for the disease. Out of 10 participants in the clinical trial, nine exhibited subjective or objective improvements within six months through a comprehensive 36-point therapeutic program. Through a combination of lifestyle changes, medication, and brain stimulation exercises, the study was developed as an alternative to clinical drug trials, most of which have failed to produce meaningful results. Currently, there are five FDA-approved drugs to provide short-term relief from common symptoms, though none treat the underlying causes. The study is the first of its kind to exhibit a reversal of memory loss associated with Alzheimer’s disease, as well one of the first to utilize a combination therapy approach similar to those developed for heart disease, HIV, and cancer.

Penn Researchers Receive International Award for Neuroscience Studies

Entrepreneur and innovator Robert Kasirer has a long history of working toward the advancement of elderly care. The California resident previously served as an executive of Golden State Health Centers, Inc., where he managed several skilled nursing centers and their ancillary divisions. Robert Kasirer also belonged to the external advisory board of the University of Pennsylvania’s Institute of Aging, where he and his colleagues offered guidance to researchers focused on advancing the quality of life for older adults.

The University of Pennsylvania’s Institute on Aging (IOA) brings together fellows from some 12 different schools at the University of Pennsylvania (Penn), and aging specialists from outside the University community. Together, these experts research and make improvements within several age-related areas, including diseases of aging, nursing, and public policy. IOA collaborates with other research centers at Penn, including the Penn Alzheimer’s Disease Center and the Penn Udall Center for Parkinson’s Disease Research.

Recently, IOA director Dr. John Q. Trojanowski was a recipient of the 2014 J. Allyn Taylor International Prize in Medicine. He was awarded the prize jointly with Virginia M.-Y. Lee, Ph.D., who co-directs the Marian S. Ware Alzheimer Drug Discovery Center at Penn with Dr. Trojanowski. Doctors Trojanowski and Lee earned the recognition from the Robarts Research Institute for their years of dedication to understanding and finding treatments for Alzheimer’s disease and other neurodegenerative disorders, such as ALS, Parkinson’s, and frontotemporal degeneration. The Robarts Research Institute at Western University acknowledged the team of Trojanowski and Lee to be among the 10 most cited neuroscientists worldwide.

Institute of Aging Presents Award for Outstanding Research Publication

An experienced owner and operator of medical facilities serving the elderly and people with disabilities, Robert Kasirer has employed his knowledge in long-term health care to benefit the Institute of Aging (IOA) at the University of Pennsylvania. For six years, Robert Kasirer sat on the organization’s External Advisory Board and, for two years, served as chairman of the board.

Established in 1979, the IOA aims to improve the health of those in the aging population. It works toward this goal by creating education programs focusing on the aging process and increasing the amount of research done on this age group. In 2012, the National Institute of Health’s National Institute on Aging ranked the IOA second in terms of total research funding obtained by an organization.

Throughout the year, the IOA hosts a number of events for its members. One such event, set to take place on November 24, 2014, at the Smilow Center for Translation Research at the University of Pennsylvania, will see presentation of the Joseph A. Pignolo, Sr. Award in Aging Research to Dongsheng Cai, MD, PhD. Dr. Cai is an Irma T. Hirschl Scholar and serves as a professor at the Albert Einstein College of Medicine’s Department of Molecular Pharmacology. The award, established by Robert J. Pignolo, MD, PhD, in memory of his father, recognizes the scientific research publication judged to be the best in the field of biogerentology in the year prior.